Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

A systematic and functional classification of Streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development.

Sanderson-Smith M, De Oliveira DM, Guglielmini J, McMillan DJ, Vu T, Holien JK, Henningham A, Steer AC, Bessen DE, Dale JB, Curtis N, Beall BW, Walker MJ, Parker MW, Carapetis JR, Van Melderen L, Sriprakash KS, Smeesters PR; M Protein Study Group..

J Infect Dis. 2014 Oct 15;210(8):1325-38. doi: 10.1093/infdis/jiu260.

3.

Streptococcus pyogenes strains in Sao Paulo, Brazil: molecular characterization as a basis for StreptInCor coverage capacity analysis.

Freschi de Barros S, De Amicis KM, Alencar R, Smeesters PR, Trunkel A, Postól E, Almeida Junior JN, Rossi F, Pignatari AC, Kalil J, Guilherme L.

BMC Infect Dis. 2015 Aug 5;15:308. doi: 10.1186/s12879-015-1052-3.

4.

[Distribution of emm genotypes and antibiotic susceptibility of Streptococcus pyogenes strains: analogy with the vaccine in development].

Arslan U, Oryaşın E, Eskin Z, Türk Dağı H, Fındık D, Tuncer I, Bozdoğan B.

Mikrobiyol Bul. 2013 Apr;47(2):318-23. Turkish.

5.

The emm-cluster typing system for Group A Streptococcus identifies epidemiologic similarities across the Pacific region.

Baroux N, D'Ortenzio E, Amédéo N, Baker C, Ali Alsuwayyid B, Dupont-Rouzeyrol M, O'Connor O, Steer A, Smeesters PR.

Clin Infect Dis. 2014 Oct;59(7):e84-92. doi: 10.1093/cid/ciu490.

6.

Genetic diversity of Group A Streptococcus M protein: implications for typing and vaccine development.

Smeesters PR, Mardulyn P, Vergison A, Leplae R, Van Melderen L.

Vaccine. 2008 Oct 29;26(46):5835-42. doi: 10.1016/j.vaccine.2008.08.037.

PMID:
18789365
7.

Host-pathogen interactions in Streptococcus pyogenes infections, with special reference to puerperal fever and a comment on vaccine development.

Areschoug T, Carlsson F, Stålhammar-Carlemalm M, Lindahl G.

Vaccine. 2004 Dec 6;22 Suppl 1:S9-S14. Review.

PMID:
15576204
8.

Region specific and worldwide distribution of collagen-binding M proteins with PARF motifs among human pathogenic streptococcal isolates.

Reissmann S, Gillen CM, Fulde M, Bergmann R, Nerlich A, Rajkumari R, Brahmadathan KN, Chhatwal GS, Nitsche-Schmitz DP.

PLoS One. 2012;7(1):e30122. doi: 10.1371/journal.pone.0030122.

9.

The emm-type diversity does not always reflect the M protein genetic diversity--is there a case for designer vaccine against GAS.

Smeesters PR, Dramaix M, Van Melderen L.

Vaccine. 2010 Jan 22;28(4):883-5. doi: 10.1016/j.vaccine.2009.10.137. No abstract available.

PMID:
19963033
10.

Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe.

Luca-Harari B, Darenberg J, Neal S, Siljander T, Strakova L, Tanna A, Creti R, Ekelund K, Koliou M, Tassios PT, van der Linden M, Straut M, Vuopio-Varkila J, Bouvet A, Efstratiou A, Schalén C, Henriques-Normark B; Strep-EURO Study Group., Jasir A.

J Clin Microbiol. 2009 Apr;47(4):1155-65. doi: 10.1128/JCM.02155-08.

11.

Membrane cofactor protein (MCP, CD46) binding to clinical isolates of Streptococcus pyogenes: binding to M type 18 strains is independent of Emm or Enn proteins.

Feito MJ, Sánchez A, Oliver MA, Pérez-Caballero D, Rodríguez de Córdoba S, Albertí S, Rojo JM.

Mol Immunol. 2007 Jul;44(14):3571-9.

PMID:
17467801
12.
13.
14.

A vaccine against S. pyogenes: design and experimental immune response.

Guilherme L, Postol E, Freschi de Barros S, Higa F, Alencar R, Lastre M, Zayas C, Puschel CR, Silva WR, Sa-Rocha LC, Sa-Rocha VM, Pérez O, Kalil J.

Methods. 2009 Dec;49(4):316-21. doi: 10.1016/j.ymeth.2009.03.024.

PMID:
19409999
15.

Non-congruent relationships between variation in emm gene sequences and the population genetic structure of group A streptococci.

Whatmore AM, Kapur V, Sullivan DJ, Musser JM, Kehoe MA.

Mol Microbiol. 1994 Nov;14(4):619-31.

PMID:
7891551
16.

Updated model of group A Streptococcus M proteins based on a comprehensive worldwide study.

McMillan DJ, Drèze PA, Vu T, Bessen DE, Guglielmini J, Steer AC, Carapetis JR, Van Melderen L, Sriprakash KS, Smeesters PR.

Clin Microbiol Infect. 2013 May;19(5):E222-9. doi: 10.1111/1469-0691.12134.

17.

Seven-year surveillance of north american pediatric group a streptococcal pharyngitis isolates.

Shulman ST, Tanz RR, Dale JB, Beall B, Kabat W, Kabat K, Cederlund E, Patel D, Rippe J, Li Z, Sakota V; North American Streptococcal Pharyngitis Surveillance Group..

Clin Infect Dis. 2009 Jul 1;49(1):78-84. doi: 10.1086/599344.

18.

Group A streptococcal Vir types are M-protein gene (emm) sequence type specific.

Gardiner DL, Goodfellow AM, Martin DR, Sriprakash KS.

J Clin Microbiol. 1998 Apr;36(4):902-7.

19.

The Streptococcus pyogenes proteome: maps, virulence factors and vaccine candidates.

Dmitriev AV, Chaussee MS.

Future Microbiol. 2010 Oct;5(10):1539-51. doi: 10.2217/fmb.10.116. Review.

20.

Novel conserved group A streptococcal proteins identified by the antigenome technology as vaccine candidates for a non-M protein-based vaccine.

Fritzer A, Senn BM, Minh DB, Hanner M, Gelbmann D, Noiges B, Henics T, Schulze K, Guzman CA, Goodacre J, von Gabain A, Nagy E, Meinke AL.

Infect Immun. 2010 Sep;78(9):4051-67. doi: 10.1128/IAI.00295-10.

Items per page

Supplemental Content

Support Center